Torthaí cuardaigh - Labianca, Roberto
- 1 - 20 toradh as 36 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Optimizing use of opiates in the management of cancer pain de réir Mandalà, Mario, Moro, Cecilia, Labianca, Roberto, Cremonesi, Marco, Barni, Sandro
Foilsithe / Cruthaithe 2006Téacs -
2
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer de réir Heinemann, Volker, Boeck, Stefan, Hinke, Axel, Labianca, Roberto, Louvet, Christophe
Foilsithe / Cruthaithe 2008Téacs -
3
-
4
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients de réir Apolone, Giovanni, Bertetto, Oscar, Caraceni, Augusto, Corli, Oscar, De Conno, Franco, Labianca, Roberto, Maltoni, Marco, Nicora, Mariaflavia, Torri, Valter, Zucco, Furio
Foilsithe / Cruthaithe 2006Téacs -
5
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study de réir Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro
Foilsithe / Cruthaithe 2011Téacs -
6
Fibrinogen: a novel predictor of responsiveness in metastatic melanoma patients treated with bio-chemotherapy: IMI (italian melanoma inter-group) trial de réir Guida, Michele, Ravaioli, Alessandra, Sileni, Vanna Chiarion, Romanini, Antonella, Labianca, Roberto, Freschi, Antonio, Brugnara, Salvatore, Casamassima, Addolorata, Lorusso, Vito, Nanni, Oriana, Ridolfi, Ruggero
Foilsithe / Cruthaithe 2003Téacs -
7
Association of Socioeconomic Status With Breslow Thickness and Disease-Free and Overall Survival in Stage I-II Primary Cutaneous Melanoma de réir Mandalà, Mario, Imberti, Gian Lorenzo, Piazzalunga, Dario, Belfiglio, Maurizio, Lucisano, Giuseppe, Labianca, Roberto, Marchesi, Lorenzo, Merelli, Barbara, Robone, Silvana, Poletti, Paola, Milesi, Laura, Tondini, Carlo
Foilsithe / Cruthaithe 2011Téacs -
8
Benefits and Adverse Events in Younger Versus Older Patients Receiving Adjuvant Chemotherapy for Colon Cancer: Findings From the Adjuvant Colon Cancer Endpoints Data Set de réir Hubbard, Joleen, Thomas, David M., Yothers, Greg, Green, Erin, Blanke, Charles, O'Connell, Michael J., Labianca, Roberto, Shi, Qian, Bleyer, Archie, de Gramont, Aimery, Sargent, Daniel
Foilsithe / Cruthaithe 2012Téacs -
9
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy de réir Sinicrope, Frank A., Foster, Nathan R., Thibodeau, Stephen N., Marsoni, Silvia, Monges, Genevieve, Labianca, Roberto, Yothers, Greg, Allegra, Carmen, Moore, Malcolm J., Gallinger, Steven, Sargent, Daniel J.
Foilsithe / Cruthaithe 2011Téacs -
10
Body Mass Index at Diagnosis and Survival Among Colon Cancer Patients Enrolled in Clinical Trials of Adjuvant Chemotherapy de réir Sinicrope, Frank A., Foster, Nathan R., Yothers, Greg, Benson, Al, Seitz, Jean Francois, Labianca, Roberto, Goldberg, Richard M., DeGramont, Aimery, O’Connell, Michael J., Sargent, Daniel J.
Foilsithe / Cruthaithe 2013Téacs -
11
The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cance... de réir Meyerhardt, Jeffrey A., Sargent, Daniel, Paul, James, Sobrero, Alberto, André, Thierry, Shields, Anthony F., Yoshino, Takayuki, Souglakos, Ioannis, Iveson, Timothy, Labianca, Roberto, Taieb, Julien, Ohtsu, Atsushi, Grothey, Axel
Foilsithe / Cruthaithe 2014Téacs -
12
The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy wi... de réir André, Thierry, Iveson, Timothy, Labianca, Roberto, Meyerhardt, Jeffrey A., Souglakos, Ioannis, Yoshino, Takayuki, Paul, James, Sobrero, Alberto, Taieb, Julien, Shields, Anthony F., Ohtsu, Atsushi, Grothey, Axel, Sargent, Daniel J.
Foilsithe / Cruthaithe 2013Téacs -
13
ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer de réir Renfro, Lindsay A., Grothey, Axel, Xue, Yuan, Saltz, Leonard B., André, Thierry, Twelves, Chris, Labianca, Roberto, Allegra, Carmen J., Alberts, Steven R., Loprinzi, Charles L., Yothers, Greg, Sargent, Daniel J.
Foilsithe / Cruthaithe 2014Téacs -
14
Epidermal Growth Factor Receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in sit... de réir Scartozzi, Mario, Bearzi, Italo, Mandolesi, Alessandra, Pierantoni, Chiara, Loupakis, Fotios, Zaniboni, Alberto, Negri, Francesca, Quadri, Antonello, Zorzi, Fausto, Galizia, Eva, Berardi, Rossana, Biscotti, Tommasina, Labianca, Roberto, Masi, Gianluca, Falcone, Alfredo, Cascinu, Stefano
Foilsithe / Cruthaithe 2009Téacs -
15
Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized Trials de réir Sargent, Daniel, Sobrero, Alberto, Grothey, Axel, O'Connell, Michael J., Buyse, Marc, Andre, Thierry, Zheng, Yan, Green, Erin, Labianca, Roberto, O'Callaghan, Chris, Seitz, Jean Francois, Francini, Guido, Haller, Daniel, Yothers, Greg, Goldberg, Richard, de Gramont, Aimery
Foilsithe / Cruthaithe 2009Téacs -
16
Validity of Adjuvant! Online in Older Patients with Stage III Colon Cancer Based on 2,967 Patients from the ACCENT Database de réir Papamichael, Demetris, Renfro, Lindsay A., Matthaiou, Christiana, Yothers, Greg, Saltz, Leonard, Guthrie, Katherine, Van Cutsem, Eric, Schmoll, Hans-Joachim, Labianca, Roberto, André, Thierry, O’Connell, Michael, Alberts, Steven R., Haller, Daniel G., Kountourakis, Panteleimon, Sargent, Daniel J.
Foilsithe / Cruthaithe 2016Téacs -
17
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the S... de réir Giampieri, Riccardo, Puzzoni, Marco, Daniele, Bruno, Ferrari, Daris, Lonardi, Sara, Zaniboni, Alberto, Cavanna, Luigi, Rosati, Gerardo, Pella, Nicoletta, Zampino, Maria Giulia, Sozzi, Pietro, Germano, Domenico, Zagonel, Vittorina, Codecà, Carla, Libertini, Michela, Labianca, Roberto, Cascinu, Stefano, Scartozzi, Mario
Foilsithe / Cruthaithe 2017Téacs -
18
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer de réir Sargent, Daniel J., Marsoni, Silvia, Monges, Genevieve, Thibodeau, Stephen N., Labianca, Roberto, Hamilton, Stanley R., French, Amy J., Kabat, Brian, Foster, Nathan R., Torri, Valter, Ribic, Christine, Grothey, Axel, Moore, Malcolm, Zaniboni, Alberto, Seitz, Jean-Francois, Sinicrope, Frank, Gallinger, Steven
Foilsithe / Cruthaithe 2010Téacs -
19
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phas... de réir André, Thierry, Meyerhardt, Jeffrey, Iveson, Timothy, Sobrero, Alberto, Yoshino, Takayuki, Souglakos, Ioannis, Grothey, Axel, Niedzwiecki, Donna, Saunders, Mark, Labianca, Roberto, Yamanaka, Takeharu, Boukovinas, Ioannis, Vernerey, Dewi, Meyers, Jeffrey, Harkin, Andrea, Torri, Valter, Oki, Eiji, Georgoulias, Vassilis, Taieb, Julien, Shields, Anthony, Shi, Qian
Foilsithe / Cruthaithe 2020Téacs -
20
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database de réir Cheung, Winson Y., Renfro, Lindsay A., Kerr, David, de Gramont, Aimery, Saltz, Leonard B., Grothey, Axel, Alberts, Steven R., Andre, Thierry, Guthrie, Katherine A., Labianca, Roberto, Francini, Guido, Seitz, Jean-Francois, O’Callaghan, Chris, Twelves, Chris, Van Cutsem, Eric, Haller, Daniel G., Yothers, Greg, Sargent, Daniel J.
Foilsithe / Cruthaithe 2016Téacs